Substandard drugs: A bitter pill to swallow
The Bureau of Investigative Journalism enlarged the story. Like earlier episodes in which paediatric syrups exported from India killed children overseas, this episode reminds us that merely having a volume lead in generics does not guarantee that India can be the 'world's pharmacy', as the government likes to advertise it.
These were the big picture stories, but the incident also has a personal, human angle. Personal stories are of course anecdotal, but that does not automatically devalue them, because we are not doing statistics here. So, to get personal, a couple of years ago, someone close to me was diagnosed with an aggressive paediatric cancer. We mostly hear of research successes, and the general impression is that cancers are becoming curable, or at least manageable. Indeed, they are, but for many cancers, treatment has not improved in 30 years. For perspective, it means that the treatment of the cancer we're talking about has not changed since V P Singh was prime minister.
A paediatric oncologist in Delhi told me a fundamental truth: 'Cancer doesn't affect only the patient, but the whole family.' That's especially true with difficult variants of the disease. The patient and family are suddenly cut off from normal life. It is as if an invisible wall stands between them and the majority who, thank heavens, have no experience of the disease. What divides these worlds is the idea that life is uncertain. Families with cancer know this; the rest of the world has gratefully forgotten it. Our legal wills still begin with the words, 'Since life is uncertain,' but we are fortunate. We take a course of pills to brush off diseases which were fearsome killers just two generations ago, like pleurisy and typhoid. After penicillin, we are no longer wired to think of untimely death as an everyday reality. Most of us feel it is unnatural to live with uncertainty.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
an hour ago
- India Today
Paneer and ghee most adulterated foods: Is homemade the safer option?
Paneer, the go-to protein source for vegetarians, is back in the spotlight, but not for good reason. Often used in daily Indian meals, or as a special shahi spread, this much-loved dairy item has come under scrutiny in Punjab after a large-scale quality test revealed that more than one-third of paneer samples were to a recent report by the Punjab Health Department, out of 531 paneer samples tested, 196 failed the quality test, and 59 were declared unsafe for consumption. The reason? Use of starch and harmful chemicals in Health Minister Dr. Balbir Singh didn't mince words when he said that these chemicals should not have been used for making paneer. "I advise people to make their own paneer at home or buy it from a certified brand like the Punjab government-owned Verka. One should minimise the purchase of paneer from the market. Earlier, women used to make paneer by boiling curdled milk at home. The same method should be put to use," he said. In the testing process, ghee didn't fare much better. Out of 222 ghee samples tested, 20 were substandard, and 28 were unsafe. And Dr. Singh had something to say about that too, especially the much-hyped A2 ghee.'There is nothing like A2 ghee,' he clarified. 'We have seen vendors selling it for Rs 2,000 to Rs 3,000 per kg. The truth is, there is no such product as A2 ghee; it's just like A1 ghee. Do not get misled. Either buy from Milkfed or make it at home. There is no rocket science in this.'Prachi Jain, Chief Clinical Nutritionist at CK Birla Hospital, Gurugram, agrees with the idea of homemade dairy. "In homemade paneer or ghee, you have control over the ingredients,' she tells 'You can use good-quality milk, preferably organic. This avoids adulteration with starch, synthetic solids, or poor-quality fats often added in commercial items.'She also points out the added benefits: 'When made at home, these items are preservative-free. Market-bought paneer and ghee could contain anti-foam agents, bleaching chemicals, or additives to extend shelf life or improve appearance.'Homemade dairy also scores on freshness and hygiene. You can maintain cleanliness at each step, from boiling the milk to filtering ghee. You also get to enjoy a better taste, smell, and nutrient another often-ignored factor: paneer sometimes contains added salt for flavour and preservation, but homemade versions are naturally low in sodium, unless you add it aside, there's also the taste and texture. 'You can tweak the firmness of paneer depending on whether you want to grill it or use it in curries,' Prachi said. 'Similarly, ghee can be light and mildly aromatic or deeply browned—your kitchen, your rules.'But is it really practical to make paneer and ghee at home? While it's the safest option, the process demands time, effort, and a lot of milk, something that doesn't quite fit into everyone's busy you can spare the effort, making your own paneer and ghee might be the healthiest, and safest, choice. Because with rising cases of adulteration, the risk might not be worth the convenience.- EndsTrending Reel
Time of India
an hour ago
- Time of India
Meet Reshma Kewalramani who joins the list of 100 Most Powerful People in Business 2025 alongside Jensen Huang, Sundar Pichai, and others
Reshma Kewalramani, born in Mumbai and now CEO of Vertex Pharmaceuticals, has earned a coveted spot on Fortune's 2025 list of the 100 Most Powerful People in Business. Ranked at number 62, she is the only Indian-origin woman CEO of a major US biotechnology company to make this year's list. Tired of too many ads? go ad free now While global names like Mark Zuckerberg, Sundar Pichai, Satya Nadella, and Mukesh Ambani also appear on the list, Kewalramani's recognition marks a monumental achievement for women in science-led industries. Her rise from a physician in Boston hospitals to the helm of a $110 billion biotech company is a remarkable journey of leadership, innovation, and impact in the global healthcare landscape. Who is Reshma Kewalramani: The Mumbai-born biotech CEO on Fortune's 2025 Most Powerful Business Leaders list Born in Mumbai, Reshma Kewalramani moved to the United States when she was just 11 years old. With a passion for medicine, she pursued her education and began her career as a physician at Massachusetts General Hospital and Brigham and Women's Hospital—two of the most prestigious medical institutions in the US. Her early experiences in clinical settings laid a strong foundation for her future in biotechnology, where patient-centered care and scientific innovation go hand in hand. In 2020, Reshma Kewalramani made history by becoming the first woman to lead a major US biotechnology company. She joined Vertex Pharmaceuticals in 2017 and quickly ascended the ranks—becoming Chief Medical Officer in 2018 and then CEO just two years later. Her appointment was more than a personal milestone—it symbolized a breakthrough in gender representation in a field traditionally dominated by men, especially at the executive level. Vertex Pharmaceuticals grows to $110 billion under Reshma Kewalramani Under her leadership, Vertex Pharmaceuticals has grown into a biotech powerhouse valued at $110 billion. Tired of too many ads? go ad free now The company is known for its innovations in treating cystic fibrosis and continues to expand its pipeline with bold research in rare diseases. Most notably in 2025, the company received FDA approval for Journavx, a revolutionary non-opioid pain treatment. This approval is being hailed as a landmark in the global fight against the opioid epidemic—a crisis that has devastated millions. Kewalramani's unique edge as a licensed physician gives her a dual perspective—scientific and strategic. Unlike many biotech CEOs who come from a purely business background, she brings hands-on clinical experience to boardroom decisions. This medical insight has been crucial in shaping Vertex's patient-first approach to drug development and innovation, further elevating its global credibility and impact. Reshma Kewalramani ranks 62 on Fortune's influential business leaders list Now in its second edition, Fortune's 100 Most Powerful People in Business celebrates individuals who wield influence, drive innovation, and shape the future of industry—not merely those with the highest net worth. Kewalramani's entry at rank 62 is a clear indication of her growing stature in the international business and biotech communities. The top ranks this year feature: Jensen Huang (CEO of Nvidia) – Rank 1 Satya Nadella (CEO of Microsoft) – Rank 2 Sundar Pichai (CEO of Google) – Rank 6 Mukesh Ambani (Chairman of Reliance Industries) – Rank 56 Neal Mohan (CEO of YouTube) – Rank 83 Gautam Adani (Industrialist) – Rank 96 While Reshma Kewalramani may not yet be a household name, her work is transforming lives. Her quiet but impactful leadership style focuses on meaningful science, global health, and diverse representation in leadership. This is her first time on the Fortune list, and it signifies global acknowledgment of her contributions not just to business, but to humanity through science. Also Read |
News18
an hour ago
- News18
'Troubled By Anti-American Forwards': Indian Doctor In US Urges Cooperation Amid Tariff War
Last Updated: Dr. Ravi Godse, a US-based Indian doctor, urged calm and cooperation amid the tariff hike on India. He also praised US' contribution in healthcare sector. As US President Donald Trump doubled the tariffs on Indian goods to a whopping 50 per cent, the decision has sparked reactions worldwide, particularly among the Indian diaspora in the US. Trump's hiked the tariffs on India, citing its direct or indirect import of Russian oil. While the move sparked heated debate, one voice calling for calm that stood out was of Dr Ravi Godse, a US-based Indian doctor, who posted a heartfelt video on Instagram appealing for reasoned dialogue, especially from India's medical community. Dr Godse expressed concern over the rise in anti-American sentiment in Indian WhatsApp groups. 'I am increasingly troubled by the mindless anti-American forwards that I see in WhatsApp groups with doctors in India. Think of our medical colleges — the medium of instruction is English. Our textbooks? All American." He also cited the Rs 15,000-crore contribution by US taxpayers to Oxford University's Covishield research and emphasized the depth of American involvement in global healthcare. 'The surgical manuals, the procedures, the robotic arms, the lenses, the prosthetics, the battery generators, pacemakers, defibrillators — all are of American design. Even if some are British or European, who funds them? American taxpayers paid ₹15,000 crore to Oxford University to study Covishield," he said in the video. He criticized knee-jerk reactions, stating, 'Why show hubris instead of humility and attitude instead of gratitude? Yes, American pharma may need Indian markets, but in a real conflict, who wins — greedy people chasing profit or needy people trying to survive?" Clarifying that India is not 'needy," Godse highlighted the country's potential to make advanced medical technologies affordable and accessible globally. 'India has a unique talent under the guidance of immensely skillful doctors to harness it and make this technology affordable and give it to the rest of the world," he added. Calling India and the US 'natural friends," he urged for cooperation over conflict. 'India and the US are natural friends. Why are we talking of conflict on World Friendship Day? Let's talk. Discussion is exchange of knowledge; argument is exchange of ignorance," he further said. The initial 25% tariff came into effect on August 7, with the additional 25% to be enforced after 21 days. Some exemptions will apply, but the trade ties between the two nations are expected to be strained. News18's viral page features trending stories, videos, and memes, covering quirky incidents, social media buzz from india and around the world, Also Download the News18 App to stay updated! view comments Location : New York, United States of America (USA) First Published: News viral 'Troubled By Anti-American Forwards': Indian Doctor In US Urges Cooperation Amid Tariff War Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
